Go Life Healthcare Limited agreed to acquire Cryo-Save South Africa Ltd., from Esperite N.V. (ENXTAM:ESP) for ZAR 20 million on June 30, 2018. For the year ended December 31, 2017, CryoSave South Africa reported revenues of ZAR 25.3 million and negative EBITDA of ZAR 2.7 million. The transaction is subject to customary closing conditions and is expected to close in third quarter of 2018. Go Life Healthcare Limited cancelled the acquisition of Cryo-Save South Africa Ltd., from Esperite N.V. (ENXTAM:ESP) on October 3, 2018. The transaction has been cancelled due to non-fulfillment of certain closing conditions, including payment of the purchase price by Go-Life Healthcare. Esperite offered to extend the deadline for the closing conditions under the sale agreement until October 21, 2018, provided it would receive payment of the purchase price (or collateral securing such payment) by September 30, 2018. Unfortunately, parties were not able to reach agreement on such extension. Unless a new sale agreement is entered between Esperite and Go-Life Healthcare, Esperite would continue to hold its stake.